Jefferies Group’s EnteroMedics Inc. ETRM Stock Holding History

Jefferies Group’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-68	Closed	-$145K	–	2680
2013 Q4	$145K	Buy	+68	New	+$110K	﹤0.01%	1660

Other funds holding ETRM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Jefferies Group's ETRM Position: Q1 2014 in Review

Jefferies Group sold out of EnteroMedics Inc. (ETRM) in Q1 2014, closing a stake of 1 share — an estimated $2K sold.

Jefferies Group first reported a position in ETRM in Q4 2013 and held it in 1 quarter. The position peaked at $2K in Q4 2013. 57 funds tracked by Wall St. Rank hold ETRM as of Q1 2014.

Jefferies Group reported no remaining EnteroMedics Inc. position as of Q1 2014 after selling out during the quarter.
Jefferies Group sold 1 EnteroMedics Inc. share in Q1 2014, an estimated $2K.
Jefferies Group first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 1 quarter.
Jefferies Group's EnteroMedics Inc. position peaked at $2K in Q4 2013.
57 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2014.

Based on Jefferies Group's 13F filing for Q1 2014, filed 16 May 2014.